Araceli Biosciences

Tigard, OR · Founded 2020 · Privately Held (backing)

Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. Araceli Biosciences is based in Tigard, OR and was founded in 2020. It was valued at $27 million at its seed round in Nov 2025, the last priced event on record. It has raised $14.5 million across 2 recorded rounds; the latest was a $12.2 million early-stage round in Dec 2024.

PMV mark · valuation
$27.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$14.5M
Last round
Early Stage VC
Dec 2024
How much has Araceli Biosciences raised?
$14.5Macross 2 recorded rounds · Apr 2023 – Dec 2024

Most recently, Araceli Biosciences raised $12.2M in its Early Stage VC (Dec 2024).

Free account
More of Araceli Biosciences with a free account
  • ·Watch Araceli Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Araceli Biosciences round by round

2 rounds
Dec 2024Early Stage VC$12.2MSEC filing▮
28 investors participated
Apr 2023Seed Round$2.2MSEC filing▮
3 investors participated

How much has Araceli Biosciences raised?

Araceli Biosciences has raised $14.5 million across 2 recorded rounds since 2023. The largest was a $2.2 million seed round in Apr 2023; the most recent was a $12.2 million early-stage round in Dec 2024.

Araceli Biosciences has filed 3 Form Ds with the SEC since 2023, most recently in Dec 2025 ($12.2 million sold to 28 investors).

Araceli Biosciences investors

2 investors are on record for Araceli Biosciences, including Fluke Venture Partners and William Cortelyou. The early-stage round in Dec 2024 drew 28 investors.

For fundraisers
Raising for a company like Araceli Biosciences?

2 investors have backed Araceli Biosciences.

See all 2 investors →

Frequently asked about Araceli Biosciences

How much has Araceli Biosciences raised?
Araceli Biosciences has raised $14.5M in total across 2 recorded funding rounds.
When was Araceli Biosciences's last funding round?
Araceli Biosciences's most recent recorded round was Early Stage VC in Dec 2024, raising $12.2M.